Inozyme Pharma Announces Presentation at the American Societ

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (NASDAQ:INZY) ("Inozyme" or the "Company"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of

Related Keywords

Boston , Massachusetts , United States , Philadelphia , Pennsylvania , American , Inozyme Pharma , Sagar Nigwekar , Stefan Riley , Matt Pera , Research Advances In Bone , Drug Administration , Inozyme Pharma Inc , European Calcified Tissue Society Congress , Facebook , Corporate Communications , American Society Of Nephrology , Kidney Research Center , Linkedin , Twitter , Exchange Commission , Mmsc Co , American Society , Kidney Week , Plasma Inorganic Pyrophosphate , Oral Abstract Session , Research Advances , Api Chewcharat , Clinical Fellow , Massachusetts General Hospital , Private Securities Litigation Reform Act , Annual Report ,